Psyence Biomedical Ltd宣布启动一项针对美国市场的战略合作计划，该计划的核心将集中于符合药品生产质量管理规范（GMP）标准的伊波加因（Ibogaine）研究及生产制造工作。
Psyence Biomedical Ltd宣布启动一项针对美国市场的战略合作计划，该计划的核心将集中于符合药品生产质量管理规范（GMP）标准的伊波加因（Ibogaine）研究及生产制造工作。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.